Key Highlights
•
A study using a mouse model found that deleting a gene called Six3 from specific brain cells that control our body’s daily clock shortened the animals’ natural circadian rhythm. This suggests Six3 plays a unique role in fine-tuning the internal clock’s timing, which could have implications for understanding sleep and metabolic disorders linked to circadian disruption.
Source →
•
Researchers warn that commonly used statistical measures for meaningful change in a person’s cognitive scores do not reliably identify which patients are actually responding to a treatment for Alzheimer’s disease. This highlights a critical gap in how we measure treatment success in clinical trials, potentially leading to misleading conclusions about a drug’s effectiveness.
Source →
•
A study analyzing data on brain bleeds caused by ruptured aneurysms found that the risk of death varies significantly depending on the specific location of the aneurysm in the brain’s blood vessels. This information is crucial for doctors to provide more accurate prognoses and tailor treatment strategies based on the aneurysm’s location.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
